CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group, announced Monday that it has broadened its exclusive ...

Download this application note to learn how the microbial detection capabilities of real-time PCR-based bacterial and fungal kits compare to those of culture-based sterility testing. You can withdraw ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Adoption of Rapid Testing Solutions: Rapid antigen tests have gained popularity in Vietnam due to their quick turnaround time and ease of use. These tests play a crucial role in screening efforts, ...

Real-Time PCR (qPCR) market Insights: Used extensively in diagnostics, life sciences, and environmental testing ...

The respiratory pathogen testing kits market is projected to grow at a 5.7% CAGR, reaching USD 7.1 billion by 2033.

Adriel Chen and Devi Sridhar discuss the outbreak of Paediatric Inflammatory Multisystem Syndrome in 2020 and consider what lessons we can learn In mid-March 2020 and into April 2020, paediatric wards ...

RT-PCR analysis of serum samples from 792 participants, collected between May and July from 2022 to 2024 identified 26 ...

Cosmos Health (COSM) has entered into a distribution agreement with Virax Biolabs Group (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits across various major European ...

But it is only now being detected more via a test that costs about Rs 15,000 to Rs 20,000.' 'The HMPV virus typically causes ...

Today the US Department of Agriculture (USDA) Food Safety and Inspection Service published its investigation findings into ...